Digestive & Intestinal Remedies (Pharmacies) - Mexico

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$261.30m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.21%, resulting in a market volume of US$277.50m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$2.02 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Mexico is experiencing steady growth due to several factors.

Customer preferences: Mexican consumers have shown a growing interest in digestive and intestinal remedies in recent years. This can be attributed to various factors such as changing dietary habits, increased stress levels, and a higher awareness of digestive health. As the population becomes more health-conscious, there is a greater demand for products that can alleviate digestive issues and promote overall well-being.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Mexico is the rising popularity of natural and herbal remedies. Consumers are increasingly seeking products that are perceived to be more natural and have fewer side effects. This has led to a shift towards herbal remedies that are derived from plants and have been traditionally used for digestive ailments. Additionally, there is a growing demand for probiotics and prebiotics, which are believed to support gut health and improve digestion. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive remedies in pharmacies. Previously, many of these products required a prescription from a healthcare professional. However, with the growing demand and the recognition of the safety and efficacy of certain OTC remedies, more and more pharmacies are stocking these products. This has made them more accessible to consumers, leading to increased sales.

Local special circumstances: Mexico has a unique culinary culture, with spicy and flavorful foods being a staple of the Mexican diet. While these foods are loved by many, they can also lead to digestive issues such as heartburn, indigestion, and stomach discomfort. This cultural aspect has contributed to the demand for digestive and intestinal remedies in the country.

Underlying macroeconomic factors: Mexico has a growing middle class and an improving economy, which has led to increased disposable income among consumers. This has allowed them to prioritize their health and spend more on healthcare products, including digestive remedies. Additionally, the country has a large population, which provides a significant customer base for the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Mexico is experiencing growth due to changing customer preferences, including a shift towards natural and herbal remedies, and the increasing availability of OTC products. The unique culinary culture of Mexico, with its spicy and flavorful foods, has also contributed to the demand for digestive remedies. The country's growing middle class and improving economy have provided consumers with more disposable income, allowing them to prioritize their health and spend more on healthcare products.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.